Evidence-Based Use of Growth Hormone in Chronic Kidney Disease: A Quality Improvement Initiative for Optimizing Outcomes (An Application-Based Activity)

CME/CE Activity

The National Kidney Foundation (NKF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), an accredited provider by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation*, an accredited provider by the Commission on Dietetic Registration (CDR) and an accredited provider by the Association for Social Work Boards (ASWB) to provide continuing education to physicians, nurses/dialysis technicians, dietitians and social workers respectively. In addition, individual activities are approved on an activity specific basis for family physicians, advanced practitioners (nurse practitioners and physician assistants), pharmacists, certified case managers, certified rehabilitation counselors, and other specialties.

*Activity approvals: Prior to January 2012 through the New York State Nurses Association (NYSNA); January 2012-December 2012 through the Ohio Nurses Association (ONA).

Available through
Nov 16, 2017
This web-based interactive virtual patient activity focuses on the issue of growth failure as a result of growth hormone dysfunction in chronic kidney disease (CKD).  Participants have the opportunity to review an expert discussion on the treatment of growth failure in CKD, with an emphasis on the role of growth hormone therapy in improving outcomes.  Recommendations for appropriate use of growth hormone therapy are presented, along with two virtual patient case studies through which participants learn how to assess, monitor, and treat patients with growth failure in CKD.     
Approved for: 1.5 **
Faculty: Bradley A. Warady, MD; John D. Mahan, MD
Cost: Free for NKF Members and non-members